Ivoclar Vivadent

Liechtenstein · www.ivoclar.com · 40 vendors

Resilience scores

Technology vendors

Services catalogue

3 services in catalogue across 1 category; runs on 40 sub-vendors.

Insights

Last updated 2026-08-06 · revision 1

40 direct vendors, 312 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 7/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Ivoclar Vivadent exhibits a moderate to high level of migration readiness, scoring 65. The existing adoption of Microsoft Azure for cloud infrastructure is a significant advantage, indicating a foundational step towards cloud-native operations and a willingness to embrace modern infrastructure. The use of Vue.js for frontend development and SAP Commerce Cloud also points to modern, cloud-compatible components within their tech stack. Vendor relationships show good geographic diversity across 10 countries, which can simplify migration planning by reducing concentration risk from any single vendor or region. However, several factors present potential challenges. The core SAP ERP system, critical for global manufacturing and logistics, can be complex and costly to migrate, especially if it's a legacy on-premise implementation. The assessment is also hampered by the lack of specified data residency requirements, which could introduce significant compliance hurdles depending on the target cloud environment. Furthermore, the absence of financial stability data means the company's capacity to fund a large-scale migration is unknown. The 'Total Vendors: 0' entry is unclear; if interpreted as a low number of actual vendors providing many services, it could imply a higher vendor lock-in risk, complicating migration efforts. Overall, while the company has made progress with cloud adoption, the potential complexities of SAP migration and critical data gaps temper its overall readiness.

Compliance

10 in-scope frameworks identified; showing 3.

PCI DSS (source) — Assessment Required

Ivoclar Vivadent operates a Webshop processing customer payment card transactions. The privacy policy explicitly states: 'When dealing with credit cards, our partner follows the Payment Card Industry Data Security Standard (PCI DSS) for the processing of payments by credit card.' This indicates PCI DSS compliance is managed through a payment processor (Paymetric is listed as a data processor). Risk is Medium because the company relies on a third-party payment processor for PCI DSS compliance, which reduces direct scope but does not eliminate it entirely — the company's systems that interact with the payment flow must also be assessed.

Evidence: https://www.ivoclar.com/en_us/legal/privacy-policy, https://www.pcisecuritystandards.org/

EU MDR — Partially Compliant

EU MDR is the most critical sector-specific regulation for Ivoclar Vivadent. As a manufacturer of dental materials (composites, ceramics, cements), dental equipment (curing lights, furnaces, CAD/CAM systems), and digital dentistry solutions, Ivoclar's products are classified as medical devices under EU MDR. Full MDR compliance (replacing MDD 93/42/EEC) was required by May 2021 for new devices and May 2024 for legacy devices (with extensions). Non-compliance risks include: inability to CE-mark products, market withdrawal, significant fines, and reputational damage. Risk is High because MDR compliance is existential for the company's EU market access — non-compliance would prevent product sales in the EU.

Evidence: https://www.ivoclar.com/en_us/eifu, https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745

ISO 13485 — Assessment Required

ISO 13485 is the internationally recognised quality management standard for medical device manufacturers and is a prerequisite for EU MDR compliance and FDA QSR/QMSR compliance. For a company of Ivoclar Vivadent's scale and product complexity, ISO 13485 certification is effectively mandatory for market access in the EU, US, Canada, Japan, and most other regulated markets. Risk is High because without ISO 13485 certification, EU MDR Notified Body assessments and FDA QMSR compliance would be severely compromised, threatening market access across all major markets.

Evidence: https://www.ivoclar.com/en_us/eifu, https://www.iso.org/standard/59752.html

Financials

Three-year financials

Financial Resilience Score: 7/10

Ivoclar demonstrates strong qualitative financial resilience despite limited public disclosure. As a privately held, family-owned company founded in 1923, it benefits from patient capital and a long-term investment horizon without public-market pressure. The company holds category leadership with its IPS e.max lithium-disilicate ceramic line, one of the industry's most widely used all-ceramic restorative materials, and operates an integrated ecosystem of materials, equipment, and software that creates recurring consumables revenue tied to installed base (razor-and-blade dynamic). The company benefits from structural demand tailwinds including aging populations, growing cosmetic-dentistry demand, and the industry shift to digital dentistry. Its global footprint across 25+ countries dampens single-market risk. Reported revenue has been broadly stable in the CHF 800M+ range in recent years, with a temporary COVID-related dip in FY2020 followed by recovery. However, resilience assessment is constrained by private-company opacity — no public disclosure of leverage, margins, or cash generation. The CHF-denominated cost base creates currency exposure against USD/EUR revenue, and the company faces intense competition from Dentsply Sirona, Straumann, 3M/Solventum, Kuraray Noritake, GC Corporation, and digital dentistry newcomers like Formlabs, SprintRay, and 3Shape/Align.

Key strengths: Category leadership in dental ceramics (IPS e.max), Integrated ecosystem of materials, equipment, and software, Family ownership with long-term investment horizon, Global footprint in 25+ countries, Structural demand tailwinds from aging populations and digital dentistry, Strong brand equity with dentists and dental labs, Recurring consumables revenue tied to installed equipment base

Risk factors: Private-company opacity limits external credit assessment, CHF cost base creates currency exposure vs USD/EUR revenue, Intense competition from Dentsply Sirona, Straumann, 3M/Solventum, Kuraray, GC, Digital dentistry newcomers (Formlabs, SprintRay, 3Shape/Align) compress equipment margins, Cyclical equipment sales tied to dental lab CapEx cycles, Regulatory compliance burden (EU MDR, FDA 510(k))

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report